drugset / Trial / NCT05093270
First-in-Human, Single- and Multiple-Ascending Dose and Food-Effect Study of BGB-23339 in Healthy Participants
RandomizedParallel-groupDouble-blindBasic science
Summary
This study will evaluate the safety, tolerability, and pharmacokinetics of BGB-23339 and food effects in healthy participants
Timeline
- Start
- 2021-11-15
- Primary completion
- 2022-09-15
- Completion
- 2022-12-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BGB-23339 | Unknown | — | Oral |
Indications
No indication recorded.